1223. Impact of Donor Lung Gram Stain on Post- Transplant Pneumonia and Mortality: More Lungs Can Be Used To Save Lives
Session: Poster Abstract Session: Transplant Screenings and Evaluation and Empiric and Pre-Emptive Therapy
Friday, October 9, 2015
Room: Poster Hall
  • IDSA Abstract 92815.pdf (273.2 kB)
  • Impact of Donor Lung Gram Stain on Post- Transplant Pneumonia and Mortality: More Lungs Can Be Used To Save Lives

    Sher Ali Khan, Emir Veledar, Cathy Logan, Sanjay Mehta, Gordon Yung, Saima Aslam

    Background: Donor lungs with gram-stain (GS) evidence of bacteria on bronchoscopy specimens are considered infected and generally deemed unsuitable for transplant. We sought to assess the impact of donor lung GS on the occurrence of post-transplant pneumonia (PTP), length of stay (LOS), and mortality.

    Methods: We retrospectively reviewed medical records of all lung transplant recipients (LTR) at our center from 12/2004-2/2014. PTP was defined by the presence of at least 2/3 criteria that occurred within 30 days of transplant: 1) symptoms, signs or laboratory markers consistent with pneumonia; 2) radiological evidence; and 3) positive respiratory culture. Statistics: Univariate and multivariate analyses, Kaplan-Meir (KM) curves, and log-rank test. 

    Results: Among 149 LTRs, 45 received donor lungs with GS positive for bacteria at the time of implantation (GS+ group) and 104 received lungs with GS negative for bacteria (GS- group). Standard immunosuppression consisted of tacrolimus, mycophenolate mofetil and steroids; induction with basiliximab was rarely used. GS+ recipients spent longer time on the wait-list (mean 416.6 vs 230.6 days, p=0.007) and were more likely to have a double lung transplant (80% vs 59.6%, p=0.02) but were otherwise similar at baseline. Receipt of GS+ lungs was associated with longer post-operative ventilator time (mean 277.4 vs 77.1 hours, p=0.045), along with prolonged intensive care unit (ICU) and overall LOS (mean 15.9 vs 9.5 days, p=0.014; mean 36.2 vs 21.7 days, p=0.005 respectively). Rate of PTP was similar in both groups (51% vs 38.5%, p=0.21) as was overall mortality (31.1% vs 35.6%, p=0.71) with similar KM curves (Figure 1, log-rank p=0.2). In multivariate analysis, GS+ group remained an independent predictor of ICU stay (OR 5.9, 95% CI 1.1-10.7, p=0.016) and LOS (OR 12.6, 95% CI 2.9-22.3, p=0.01).

    Conclusion: Use of donor lungs that are gram-stain positive for bacteria is associated with longer time on the ventilator, and in the ICU and hospital. However, it does not impact the development of pneumonia in the first 30 days post-transplant or mortality. Hence, criteria for use of donor lungs should be liberalized with the potential to save more lives.

    Sher Ali Khan, MBBS1, Emir Veledar, PhD2, Cathy Logan, MD3, Sanjay Mehta, MD4, Gordon Yung, MD3 and Saima Aslam, MD, MS5, (1)Medicine, UCSD, San Diego, CA, (2)Florida International University, Miami, FL, (3)UCSD, San Diego, CA, (4)Medicine, University of California, San Diego, La Jolla, CA, (5)Division of Infectious Disease, University of California, San Diego, La Jolla, CA


    S. A. Khan, None

    E. Veledar, None

    C. Logan, None

    S. Mehta, None

    G. Yung, None

    S. Aslam, None

    Previous Abstract | Next Abstract >>

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.